Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 1997

View Archived Issues

Annual Report: Triangle Pharmaceuticals

TK signal transduction modulators claimed by Sugen

BASF focuses on dolastatin derivatives

Novel anti-HIV compounds disclosed by Novartis

Chiron prepares uPA inhibitors

Human Genome Sciences discloses novel human polypeptide for cancer

Apoptosis-regulating factor discovered

German launch for ACE inhibitor

German introduction for hepatitis vaccine

Third launch for Zyprexa

Comparative study of second-generation t-PA inhibitor and alteplase

GDNF gene therapy for Parkinson's disease

Vaginal antifungal product cleared by FDA

Ampalex trial in AD begins

Magainin lead product licensed to SKB

Labeled SMART antibody shows promise for AML treatment

Encouraging results obtained for immunotoxin in Hodgkin's lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Peptidream reveals milestone in Alnylam collaboration
BioWorld Science
Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...